Seattle’s Fred Hutchinson Cancer Research Center is already well known for spinning out biotechnology companies, such as Juno Therapeutics and Blaze Bioscience. Now, however, the center is trying to increase the number of companies, as well as patents and licenses, that it produces.
Fred Hutch’s push for more commercialization has the potential to make Seattle into an even bigger hub for biotech innovation and to attract more investors to the region’s biotech research
